Skip to main content
Figure 3 | AIDS Research and Therapy

Figure 3

From: Failure of combined antiretroviral therapy intensification with maraviroc and raltegravir in chronically HIV-1 infected patients to reduce the viral reservoir: the IntensHIV randomized trial

Figure 3

Evolution in the 2 arms of PBMCs viral markers over 48 weeks in the 2 arms. 3a: proviral HIV-1 DNA in PBMC. 3b: HIV-1 ARN in PBMCs. Arm 1: intensified. Arm 2: controls. Results are shown as means with 95% confidence intervals (bars). *non-parametric paired test: p = 0.07 compared to baseline; **p = 0.06 compared to baseline.

Back to article page